Skip to content


Cancer Imaging

Open Access

Utility of dual time point 18 FDG PET-CT

  • SE De Luca1Email author,
  • JE Codas Thompson1,
  • E Casalini Vañek1,
  • H Campanelli1,
  • C Carrera1 and
  • EP Eyheremendy1
Cancer Imaging201414(Suppl 1):P24

Published: 9 October 2014

The Standardized Uptake Value (SUV) from FDG PET-CT is a simplified quantitative measure used for characterization of tissues suspected for malignancy. Its rationale is based in augmented glucose consumption of oncologic cells although, many other benign pathologies, could show elevated values leading to error.

The purpose of this presentation is to demonstrate that SUV value continues elevating in malignant pathology while in benign disease will decrease over time.

We prospectively acquired delayed images in patients with focal increase of metabolic activity without clear morphologic pathology, or failing to show increase metabolic activity in sites with morphological findings of probable oncologic origin. We have acquired delayed evaluation in 45 patients with suspicious lesions.

The most prominent findings were: 11 patients with focal hypermetabolic sites in gastrointestinal tract who demonstrate significant SUV decline on delayed images, avoiding unnecessary colonoscopies, while another 17 patients have significantly increased SUV on delayed images, correlated with polypoid lesions at colonoscopy. 7 patients with falling SUV on delayed images in adnexal hypermetabolic foci proved to be of functional origin at ultrasound follow-up, 5 patients with descending SUV at delayed images in hypermetabolic foci in the neck proved to be inflammatory on follow-up and 5 patients that SUV value continues elevating on delayed images, secondary or primary origin was confirmed.

Dual time point PET-CT has proven to be an important tool for proper characterization of questionable lesions that would lead to costly mistakes or unnecessary diagnostic studies.

Authors’ Affiliations

Hospital Alemán, Buenos Aires, Argentina


© De Luca et al; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.